Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, including adeno-associated virus (AAV) gene therapies, as well as related consulting activities, project management and regulatory support.
Microbiology Product Areas
Pharmaceutical
Adeno-associated virus (AAV)
Show all suppliersATMP - Advanced Therapeutic Medicinal Products
Show all suppliersCell and Gene Therapies
Show all suppliersContract Research Organization (CRO)
Show all suppliersGene and Cell Therapies
Show all suppliersLATEST MICROBIOLOGY NEWS
-
SpeciSafe® Streamlines Patient Sample Transport
01 Apr 2026 -
2026 CLSI and EUCAST Guidelines in BIOMIC® V3
30 Mar 2026 -
Webinar - Analysis of Surface-attached Biofilm
30 Mar 2026
MICROBIOLOGY EVENTS
-
ESCMID Global 2026
17 Apr 2026 -
Analysis of Surface-attached Biofilm
21 Apr 2026 -
Foreign Supplier Verification Program (FSVP) Responsibilities and Compliance
23 Apr 2026 -
Essentials Of USP Microbiology - Reading Between the Lines of the USP General
28 Apr 2026 -
A Practical Introduction to Sterile Manufacturing
28 Apr 2026 -
Essentials Of USP Microbiology
28 Apr 2026 -
Practical Considerations for Qualification and Operation of Pharmaceutical Isolators
29 Apr 2026 -
GENAP Summit 2026
5 May 2026 -
FoodRevolution® 2026
11 May 2026 -
SLAS Europe 2026 Conference and Exhibition
19 May 2026